SCHEMBL7007472

SCHEMBL7007472

C=CC(N)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25937520 1.00
SCHEMBL21573896 0.76
SCHEMBL11260854 0.76
SCHEMBL10641699 0.75 LMNA (0.35)
SCHEMBL3369870 0.75 TSHR (0.39)
SCHEMBL23740957 0.73
SCHEMBL18203774 0.73
SCHEMBL8057279 0.73
SCHEMBL19406700 0.73
SCHEMBL175223 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107365418-B Polyallylamine derivatives 味之素株式会社 2022-04-01 CN disclosed
EP-1349853-A2 ANTIMICROBIAL QUINOLONE DERIVATIVES AND USE OF THE SAME TO TREAT BACTERIAL INFECTIONS Pharmacia &amp; Upjohn Company (US) 2003-10-08 EP disclosed
WO-2002059116-A2 ANTIMICROBIAL QUINOLONE DERIVATIVES AND USE OF THE SAME TO TREAT BACTERIAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 2002-08-01 WO disclosed
US-5371086-A Circulatory disorders side effect reduction THE GREEN CROSS CORPORATION (JP) 1994-12-06 US disclosed
US-5262415-A FOR TREATING DISEASES OF THE CIRCULATORY SYSTEM THE GREEN CROSS CORPORATION (JP) 1993-11-16 US disclosed
EP-0503627-A1 Aminopyridine compounds THE GREEN CROSS CORPORATION (JP) 1992-09-16 EP disclosed
US-3956297-A 9H-Dibenzo[b,f]imidazo[1,2-d][1,4]diazepines THE UPJOHN COMPANY (US) 1976-05-11 US disclosed